1. Home
  2. SMID vs LCTX Comparison

SMID vs LCTX Comparison

Compare SMID & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

N/A

Current Price

$24.11

Market Cap

128.8M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.97

Market Cap

255.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SMID
LCTX
Founded
1960
1990
Country
United States
United States
Employees
188
N/A
Industry
Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.8M
255.4M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
SMID
LCTX
Price
$24.11
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
9.6K
★ 1.2M
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.76
N/A
EPS
★ 0.51
N/A
Revenue
★ $93,446,000.00
$14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
N/A
N/A
P/E Ratio
$47.61
★ N/A
Revenue Growth
19.03
★ 53.24
52 Week Low
$23.51
$0.91
52 Week High
$42.15
$2.09

Technical Indicators

Market Signals
Indicator
SMID
LCTX
Relative Strength Index (RSI) 35.90 42.53
Support Level $23.51 N/A
Resistance Level $25.25 $1.18
Average True Range (ATR) 0.74 0.06
MACD 0.06 -0.00
Stochastic Oscillator 14.35 37.11

Price Performance

Historical Comparison
SMID
LCTX

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: